blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2029546

EP2029546 - ARYL-SUBSTITUTED HETEROCYCLES, AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.06.2011
Database last updated on 21.05.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
[2009/32]
Former [2009/10]For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
Inventor(s)01 / HÄRTER, Michael
Ernst-Ludwig-Kirchner-Str. 56
51375 Leverkusen / DE
02 / WUNBERG, Tobias
Gaadner Strasse 78/3
2371 Hinterbrühl / AT
03 / ALLERHEILIGEN, Swen
Beckumsfeld 4
45259 Essen / DE
04 / BAUSER, Marcus
Mozartstrasse 7
42115 Wuppertal / DE
05 / RESTER, Ulrich
Sadowastr. 35
42115 Wuppertal / DE
06 / HEITMEIER, Stefan
Am Wasserturm 56
42489 Wülfrath / DE
 [2009/10]
Application number, filing date07725589.125.05.2007
[2009/10]
WO2007EP04693
Priority number, dateDE2006102531431.05.2006         Original published format: DE102006025314
[2009/10]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2007137791
Date:06.12.2007
Language:DE
[2007/49]
Type: A1 Application with search report 
No.:EP2029546
Date:04.03.2009
Language:DE
The application published by WIPO in one of the EPO official languages on 06.12.2007 takes the place of the publication of the European patent application.
[2009/10]
Type: B1 Patent specification 
No.:EP2029546
Date:28.07.2010
Language:DE
[2010/30]
Search report(s)International search report - published on:EP06.12.2007
ClassificationIPC:C07D231/12, C07D401/04, C07D417/12, C07D417/14, C07D419/14, A61P7/02
[2009/10]
CPC:
C07D409/14 (EP,US); A61P43/00 (EP); A61P7/02 (EP);
C07D231/12 (EP,US); C07D413/14 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/10]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:ARYL-SUBSTITUIERTE HETEROZYKLEN UND IHRE VERWENDUNG[2009/10]
English:ARYL-SUBSTITUTED HETEROCYCLES, AND USE THEREOF[2009/10]
French:HÉTÉROCYCLES SUBSTITUÉS PAR UN ARYLE ET LEUR UTILISATION[2009/10]
Entry into regional phase05.01.2009National basic fee paid 
05.01.2009Designation fee(s) paid 
05.01.2009Examination fee paid 
Examination procedure05.01.2009Examination requested  [2009/10]
19.03.2009Despatch of a communication from the examining division (Time limit: M06)
08.09.2009Reply to a communication from the examining division
18.02.2010Communication of intention to grant the patent
14.06.2010Fee for grant paid
14.06.2010Fee for publishing/printing paid
Opposition(s)29.04.2011No opposition filed within time limit [2011/27]
Fees paidRenewal fee
02.06.2009Renewal fee patent year 03
31.05.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY28.07.2010
CZ28.07.2010
DK28.07.2010
EE28.07.2010
FI28.07.2010
HU28.07.2010
IE28.07.2010
LT28.07.2010
LV28.07.2010
MT28.07.2010
NL28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
TR28.07.2010
BG28.10.2010
GR29.10.2010
IS28.11.2010
PT29.11.2010
[2013/45]
Former [2013/44]CY28.07.2010
CZ28.07.2010
DK28.07.2010
EE28.07.2010
FI28.07.2010
IE28.07.2010
LT28.07.2010
LV28.07.2010
MT28.07.2010
NL28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
TR28.07.2010
BG28.10.2010
GR29.10.2010
IS28.11.2010
PT29.11.2010
Former [2012/05]CY28.07.2010
CZ28.07.2010
DK28.07.2010
EE28.07.2010
FI28.07.2010
IE28.07.2010
LT28.07.2010
LV28.07.2010
MT28.07.2010
NL28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
BG28.10.2010
GR29.10.2010
IS28.11.2010
PT29.11.2010
Former [2011/26]CY28.07.2010
CZ28.07.2010
DK28.07.2010
EE28.07.2010
FI28.07.2010
IE28.07.2010
LT28.07.2010
LV28.07.2010
NL28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
BG28.10.2010
GR29.10.2010
IS28.11.2010
PT29.11.2010
Cited inInternational search[A]WO2005032468  (BRISTOL MYERS SQUIBB CO [US], et al) [A] 1,4-14* paragraph [0571] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.